Introduction
In many species, including humans, exposure to inorganic arsenic results in urinary excretion of methylated and dimethylated arsenicals [1] [2] [3] . Cullen and co-workers [4] summarized the conversion of inorganic arsenic into these methylated products in a reaction scheme which incorporates oxidative methylation and the cycling of arsenic between the pentavalent (As V ) 1 Because reduction of arsenic to trivalency is a prerequisite for its oxidative methylation, pentavalent arsenicals are reduced by endogenous thiols such as glutathione (GSH) [5, 6] or by As V reductases [7] [8] [9] . A protein has been purified from rabbit liver cytosol that catalyzes the methylation of both arsenite and methylarsonous acid [10, 11] ; however, this protein has not been sequenced. These activities are designated arsenite methyltransferase (E.C. 2.1.1.137) and methylarsonite methyltransferase (E.C. 2.1.1.138), respectively. This protein (estimated molecular mass 60 kDa) uses S-adenosyl-L-methionine (AdoMet) as the methyl group donor.
The methylation of arsenite by this protein is stimulated by a monothiol (GSH) and the methylation of methylarsonous acid is highly stimulated by a dithiol, dithiothreitol (DTT).
The methylation of arsenic has been commonly regarded as a mechanism for its 1 The abbreviations used are: AdoMet, S-adenosyl-L-methionine; As detoxification [12] . However, recent research has shown that methylated arsenicals that contain As III are important intermediates in the metabolism of inorganic arsenic. Methylated arsenicals that contain As III are found in the urine of individuals who chronically consume drinking water that contains inorganic arsenic and in cells cultured in the presence of arsenite [13] [14] [15] [16] [17] [18] . These As III -containing metabolites are more cytotoxic and genotoxic than either arsenate or arsenite [19] [20] [21] . Methylated arsenicals that contain As III are also more potent than arsenite as inhibitors of the activities of various enzymes, including GSH reductase [22, 23] , thioredoxin reductase [24, 25] , and pyruvate dehydrogenase [26] . These results suggest that the methylation process can be properly regarded as a means for the activation of inorganic arsenic to more reactive and toxic species. Consequently, characterization of enzymes that catalyze formation of methylated arsenicals is an important step in understanding the consequences of chronic exposure to inorganic arsenic.
Although there are extensive data on the kinetics of formation of methylated arsenicals in in vitro systems containing crude cytosolic preparations or purified enzyme, in cultured cells, and in intact animals, little is known about the properties of the enzymes that catalyze the methylation reactions. The work reported here describes the purification of a novel protein from rat liver cytosol that catalyzes the time-dependent formation of methylated and dimethylated arsenicals in reaction mixtures that contain the purified protein, arsenite, GSH, DTT, and AdoMet. Massspectrometric sequencing of peptides generated from this protein indicates a high degree of homology with Cyt19, a putative methyltransferase of unknown function that is expressed in mouse and human tissues. Using degenerate oligonucleotide primers based on the amino acid sequence of peptides from the purified protein, the complete nucleotide sequence of the mRNA encoding the protein has been determined. This novel protein is designated S-adenosyl-L- . Fractions that contained the highest levels of the activity that converted arsenite to methylated and dimethylated products were pooled and applied to a column of an S-adenosyl-L-homocysteine-Sepharose affinity gel that was prepared by the method of Reeve and co-workers kV. The extracts were analyzed using the instrument's double play capability. Here, full scan mass spectra were acquired to determine the molecular weights of peptides and product ion spectra were acquired to determine the amino acid sequence in sequential scans. This mode of analysis yields about 400 CAD spectra of ions that range in abundance over several orders of magnitude. Data were analyzed by database searching using the Sequest search algorithm.
Peptides that were not matched by this algorithm were interpreted manually and searched in the EST databases using the Sequest algorithm.
Determination of mRNA Sequence -Total RNA was isolated from the livers of adult male Fischer 344 rat using Trizol reagent (GIBCO/BRL). Total RNA was treated with DNase (GIBCO/BRL) and cDNA was made using Promega Reverse Transcriptase System. A set of degenerate oligonucleotide primers for use in polymerase chain reactions (PCR) were designed on the basis of the translation of peptide sequences from S-adenosyl-L-methionine: arsenic(III) methyltransferase. With these primers, the cDNA was amplified using Hot Start PCR and Ampli Taq Gold enzyme (Perkin Elmer). PCR products were purified using QIAquick PCR purification.
A 900-base sequence was obtained and was sequenced at the UNC-CH Automated DNA Sequencing Facility on a Model 377 DNA Sequencer (Applied Biosystems) using the ABI Prism™ Dye Terminator Cycle Sequencing Ready Reaction Kit with AmpliTaq DNA polymerase. Using this sequence information, the sequences of the 5 and 3 ends were obtained using the GeneRacer system (Invitrogen). The resulting cDNAs were sequenced, providing the entire mRNA sequence. were separated on a 1% agarose gel and stained with ethidium bromide.
Reverse Transcription (RT)-PCR Analysis of Gene Expression

Results
Protein Purification and Reaction Characteristics -A combination of acid treatment of cytosol, chromatofocusing, and affinity chromatography on an S-adenosyl-L-homocysteine-Sepharose gel
column allowed 9300-fold enrichment of S-adenosyl-L-methionine: arsenic(III) methyltransferase activity from rat liver cytosol (Table 1) . Notably, the total activity of S-adenosyl-L-methionine:
arsenic(III) methyltransferase recovered in this purification scheme increased as the specific activity of the fractions increased. The enhanced yield may reflect removal of an endogenous inhibitor of the enzyme's activity in the purification scheme or an altered ratio of enzyme to DTT as purification progresses. A critical factor in the success of this purification scheme was inclusion of GSH and DTT in all buffers. Earlier work demonstrated that GSH was critical to the maintenance of arsenic methylating activity in an in vitro reaction system that contained rat liver cytosol [33, 34] and that DTT promoted the dimethylation reaction catalyzed by the purified rabbit liver protein [10] . S-adenosyl-L-homocysteine-Sepharose affinity chromatography yielded Substantial activity was found between pH 7.5 and 10 with peak activity at pH 9.5.
Peptide and cDNA Sequencing -Mass spectrometry of the purified protein provide 15 unique peptide sequences (Table 2) . BLASTP analysis found a high degree of identity between these peptides and the predicted sequences of two proteins (NCB accession # NP065602 and by guest on http://www.jbc.org/ Downloaded from NP05733). These proteins of mouse and human origin, respectively, have been provisionally identified as methyltransferases and designated as Cyt19. Using peptide sequence data, a set of degenerate oligonucleotide primers was designed for PCR and subsequent sequencing of the products (Table 3) . Based on initial sequence results, additional oligonucleotide primers were synthesized to complete the sequencing of the full-length cDNA. The sequence of the full-length cDNA for S-adenosyl-L-methionine: arsenic(III) methyltransferase and its conceptual translation are shown in Table 4 . The predicted protein contains 369 amino acids and has a calculated molecular mass of 41056. 14 cultured cells [20] . AdoMet served as the methyl group donor for both reactions. These results are consistent with evidence that trivalent arsenicals are the preferred substrate for this enzyme and that the pentavalent arsenicals must be reduced enzymatically or non-enzymatically before methylation [7, 11, 41] . Based on estimated molecular weights, the protein purified from rat liver cytosol (~ 42 kDa) is probably not identical with the enzyme purified from rabbit liver cytosol (~ 60 kDa) that catalyzes the methylation of arsenite and methylarsonous acid [10, 11] . S-Adenosyl- However, the smaller molecular mass of this enzyme (29.5 kDa) and its dissimilar amino acid sequence [43] indicate a lack of identity with S-adenosyl-L-methionine: arsenic(III) methyltransferase. Hsieh and Ganther [44] described two activities from rat liver and kidney that catalyze the synthesis of dimethyl selenide, a protein from the cytosolic fraction with a molecular mass of about 30 kDa, and an activity in the microsomal fraction that catalyzes this reaction. The protein purified in the present work is not likely to be identical with these proteins. S-Adenosyl-L-methionine: arsenic(III) methyltransferase mRNA was detected in many rat tissues. Studies in in vitro systems containing cytosolic fractions prepared from rat liver or kidney have shown that arsenite is methylated in both tissues [33, 34, 45] . Arsenic methylating activity has also been detected in cytosolic fractions prepared from mouse liver, kidney, lung, and testes [46] . Both methylated and dimethylated arsenicals have been detected in livers and kidneys of arsenite-treated rats [47] . Hence, the occurrence of S-adenosyl-L-methionine: arsenic(III) methyltransferase mRNA in rat tissues is consistent with evidence for the methylation of arsenic in these tissues. HepG2 cells expressed fairly high levels of S-adenosyl-L-methionine:
Expression of S-
arsenic(III) methyltransferase mRNA. These cells are efficient methylators of arsenite, containing both methylated and dimethylated products [18] . In contrast, UROtsa cells which do not express this mRNA do not methylate arsenic [20] . h is a hydrophobic amino acid, X is any amino acid, and the position of glycine residues is strongly conserved [49] . Motif I has been associated with the binding of AdoMet by the enzyme and mutation of the conserved glycine residues in motif I in guanidinoacetate methyltransferase abolished its catalytic activity [50] . An acidic residue which contributes to the binding of AdoMet has been found between 17 to 19 residues C-terminal to the end of motif I [48, 50] . In Sadenosyl-L-methionine: arsenic(III) methyltransferase and human Cyt19, aspartate was found 20
residues C-terminal to the end of motif I. As in other methyltransferases, this aspartate residue was preceded by a hydrophobic amino acid, isoleucine. Motif II with the consensus sequence suggested that genotypic differences in the activities of the enzyme that methylates arsenic or in enzymes involved in the recycling of homocysteine used in the synthesis of AdoMet could be the sources of variability among individuals in the urinary output of methylated arsenicals. To this list could be added genotypic differences in the activity of the reductases that convert arsenate and methylarsonic acid to arsenite and methylarsonous acid [7, 8] . Additional studies of polymorphisms of S-adenosyl-L-methionine: arsenic(III) methyltransferase will be required to determine the contribution of this factor to differences among individuals in metabolism, b. Total activity (pmols of methylated and dimethylated arsenic formed) is the product of the specific activity of a fraction and the total protein content of that fraction. 
